BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18725321)

  • 1. Aflatoxin B1-induced TP53 mutational pattern in normal human cells using the FASAY (Functional Analysis of Separated Alleles in Yeast).
    Paget V; Sichel F; Garon D; Lechevrel M
    Mutat Res; 2008 Oct; 656(1-2):55-61. PubMed ID: 18725321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetaldehyde-induced mutational pattern in the tumour suppressor gene TP53 analysed by use of a functional assay, the FASAY (functional analysis of separated alleles in yeast).
    Paget V; Lechevrel M; Sichel F
    Mutat Res; 2008 Mar; 652(1):12-9. PubMed ID: 18242117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The p53 codon 249 mutational hotspot in hepatocellular carcinoma is not related to selective formation or persistence of aflatoxin B1 adducts.
    Denissenko MF; Koudriakova TB; Smith L; O'Connor TR; Riggs AD; Pfeifer GP
    Oncogene; 1998 Dec; 17(23):3007-14. PubMed ID: 9881702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors.
    Tam AS; Foley JF; Devereux TR; Maronpot RR; Massey TE
    Cancer Res; 1999 Aug; 59(15):3634-40. PubMed ID: 10446974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan.
    Shirabe K; Toshima T; Taketomi A; Taguchi K; Yoshizumi T; Uchiyama H; Harimoto N; Kajiyama K; Egashira A; Maehara Y
    Liver Int; 2011 Oct; 31(9):1366-72. PubMed ID: 21745313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagenesis of the H-ras protooncogene and the p53 tumor suppressor gene.
    Cerutti P; Hussain P; Pourzand C; Aguilar F
    Cancer Res; 1994 Apr; 54(7 Suppl):1934s-1938s. PubMed ID: 7907948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aflatoxin B1-induced rat hepatic hyperplastic nodules do not exhibit a site-specific mutation within the p53 gene.
    Hulla JE; Chen ZY; Eaton DL
    Cancer Res; 1993 Jan; 53(1):9-11. PubMed ID: 8380129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aflatoxin B1 induces the transversion of G-->T in codon 249 of the p53 tumor suppressor gene in human hepatocytes.
    Aguilar F; Hussain SP; Cerutti P
    Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8586-90. PubMed ID: 8397412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional analysis of chemically-induced mutations at the flounder TP53 locus, the FACIM assay.
    Cachot J; Couteau J; Frébourg T; Leboulenger F; Flaman JM
    Mutat Res; 2004 Aug; 552(1-2):51-60. PubMed ID: 15288541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aflatoxin B1-induced DNA adduct formation and p53 mutations in CYP450-expressing human liver cell lines.
    Macé K; Aguilar F; Wang JS; Vautravers P; Gómez-Lechón M; Gonzalez FJ; Groopman J; Harris CC; Pfeifer AM
    Carcinogenesis; 1997 Jul; 18(7):1291-7. PubMed ID: 9230270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational signature of the proximate bladder carcinogen N-hydroxy-4-acetylaminobiphenyl: inconsistency with the p53 mutational spectrum in bladder cancer.
    Besaratinia A; Bates SE; Pfeifer GP
    Cancer Res; 2002 Aug; 62(15):4331-8. PubMed ID: 12154037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer.
    Olivier M; Hussain SP; Caron de Fromentel C; Hainaut P; Harris CC
    IARC Sci Publ; 2004; (157):247-70. PubMed ID: 15055300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular mechanism of mutagenesis induced by aflatoxin B1 using a shuttle vector pSP189/mammalian cell system].
    Tan X; Li S; Luo X; Zhou Y
    Wei Sheng Yan Jiu; 1997 Jul; 26(4):271-7. PubMed ID: 10325601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzo[a]pyrene, aflatoxine B₁ and acetaldehyde mutational patterns in TP53 gene using a functional assay: relevance to human cancer aetiology.
    Paget V; Lechevrel M; André V; Goff JL; Pottier D; Billet S; Garçon G; Shirali P; Sichel F
    PLoS One; 2012; 7(2):e30921. PubMed ID: 22319594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzene-induced mutational pattern in the tumour suppressor gene TP53 analysed by use of a functional assay, the functional analysis of separated alleles in yeast, in human lung cells.
    Billet S; Paget V; Garçon G; Heutte N; André V; Shirali P; Sichel F
    Arch Toxicol; 2010 Feb; 84(2):99-107. PubMed ID: 19862502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro mutational spectrum of aflatoxin B1 in the human hypoxanthine guanine phosphoribosyltransferase gene.
    Cariello NF; Cui L; Skopek TR
    Cancer Res; 1994 Aug; 54(16):4436-41. PubMed ID: 8044792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sequence alterations in p53 gene of hepatocellular carcinoma from high aflatoxin risk area in Guangxi].
    Deng Z; Pan L; Ma Y
    Zhonghua Zhong Liu Za Zhi; 1997 Jan; 19(1):18-21. PubMed ID: 10743047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations associated with in vivo aflatoxin B1-induced carcinogenesis need not be present in the in vitro transformations by this toxin.
    Stanley LA; Mandel HG; Riley J; Sinha S; Higginson FM; Judah DJ; Neal GE
    Cancer Lett; 1999 Apr; 137(2):173-81. PubMed ID: 10374839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations of the p53 tumor suppressor gene and ras oncogenes in aflatoxin hepatocarcinogenesis.
    Shen HM; Ong CN
    Mutat Res; 1996 Oct; 366(1):23-44. PubMed ID: 8921985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro recapitulating of TP53 mutagenesis in hepatocellular carcinoma associated with dietary aflatoxin B1 exposure.
    Besaratinia A; Kim SI; Hainaut P; Pfeifer GP
    Gastroenterology; 2009 Sep; 137(3):1127-37, 1137.e1-5. PubMed ID: 19524575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.